June 18, 2025- Despite the rising incidence of diabetes in the U.S., we have never been in a better position to use the tools at our disposal to effectively screen the population for diabetes.
By Jim Poggi, Principal, Tested Insights
Did you ever wonder: if lab testing impacts about 70% of all medical decisions, and if diabetes has been a known disease entity for over 3,500 years, and glucose testing has been a key element of our diagnostic arsenal for over 50 years, then why is diabetes incidence continuing to increase in the U.S.?
At the same time, it is right to ask “Are recent advances in treatment for type 2 diabetes going to help? Is our battle with diabetes at a pivot point? Have we moved on from treatment programs that put responsibility for management of type 2 diabetes (reduce carbohydrate intake, get more exercise and measure their glucose level as frequently as directed by the physician) on the patient who is likely resistant to needed life changes? Are there newer diagnostic and therapeutic tools that will assure a higher level of success in diabetic management?”
In this column, I intend to explore some of the history of diabetes, how we got where we are today and some speculation regarding where diagnosis and treatment of diabetes may go over the next few years. Spoiler alert: I do believe we are approaching a pivot point where diagnostics, treatment and patient compliance are all heading in the direction we need to reduce the incidence, cost and complications of this difficult-to-treat disease.
Continue Reading in the latest issue of Repertoire Magazine.